Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells


The Company
Stemline Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics that target both cancer stem cells (CSCs) and tumor bulk.
Clinical Trials
Cancer Stem Cells
Platform
Stemline Therapeutics has developed a Discovery Platform called StemScreen to identify novel compounds that target and kill CSCs.


News
&
Events
6/23/2015
Stemline Therapeutics to Present at the JMP Securities Life Sciences Conference
6/1/2015
Stemline Therapeutics to Present at the Jefferies 2015 Healthcare Conference
5/28/2015
Stemline Announces Top-Line Results From Lead-In Stage of BPDCN Pivotal Trial
Copyright 2015 - Stemline Therapeutics, Inc. All rights reserved
Stemline